Michael MBA - Chimerix President CEO

CMRX Stock  USD 0.89  0.01  1.11%   

CEO

Michael MBA is President CEO of Chimerix
Age 51
Phone919 806 1074
Webhttps://www.chimerix.com

Chimerix Management Efficiency

The company has return on total asset (ROA) of (0.3022) % which means that it has lost $0.3022 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4859) %, meaning that it created substantial loss on money invested by shareholders. Chimerix's management efficiency ratios could be used to measure how well Chimerix manages its routine affairs as well as how well it operates its assets and liabilities.
Chimerix currently holds 1.3 M in liabilities with Debt to Equity (D/E) ratio of 0.1, which may suggest the company is not taking enough advantage from borrowing. Chimerix has a current ratio of 2.14, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Chimerix's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 5 records

CEO Age

Jeremy MBADay One Biopharmaceuticals
53
Paula RaganX4 Pharmaceuticals
54
Denise ScotsKnightMereo BioPharma Group
65
Amy MBATerns Pharmaceuticals
54
Jason OkazakiAssembly Biosciences
48
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. Chimerix (CMRX) is traded on NASDAQ Exchange in USA. It is located in 2505 Meridian Parkway, Durham, NC, United States, 27713 and employs 72 people. Chimerix is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Chimerix Leadership Team

Elected by the shareholders, the Chimerix's board of directors comprises two types of representatives: Chimerix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chimerix. The board's role is to monitor Chimerix's management team and ensure that shareholders' interests are well served. Chimerix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chimerix's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBA, Chief Officer
Michael MBA, President CEO
David CPA, Exec Officer
Joshua Allen, Chief Imipridones
Dr MBA, Chief Officer
Michael Alrutz, interim CEO, Senior Vice President General Counsel
Pablo MD, Head Affairs
Roy Ware, Chief Manufacturing and Technology Officer
Thomas Riga, Chief Officer
Dr JD, General VP
Randall Lanier, Chief Science Officer
Michelle LaSpaluto, Chief Officer

Chimerix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chimerix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Chimerix Stock Analysis

When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.